ArticleClinical and translational medicine2021

The oral KIF11 inhibitor 4SC-205 exhibits antitumor activity and potentiates standard and targeted therapies in primary and metastatic neuroblastoma models.

Marc Masanas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.